Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer

Clinical trial NCT00345761 · COMPLETED

Trial details

NCT number: NCT00345761
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2006-02-01
Primary completion: 2008-10-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.